6 min read
Veristat, a full-service CRO, can guide you through the planning and development process to help you successfully bring a new
myeloma cancer treatment to market. With 41% of our work in oncology trials and extensive experience with myeloma, Veristat can help advance your compound through the submission process. Our teams will collaborate to build the optimal program based upon the science of your product, while providing key functional services, including trial design, clinical monitoring, data management, medical writing and statistical consultation with regulatory representation.
|
Contact our team to learn more about our oncology experience, the work we have performed in the area of myeloma and how we can help you.
|
WORKING TOGETHER. The Veristat Oncology team:
Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial. |
Get the Latest News
Categories
- Regulatory Consulting (122)
- Regulatory Submissions (117)
- Clinical Trial Regulations (102)
- COVID-19 (46)
- Strategic Consulting (30)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Oncology (11)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Medical Writing (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
2 min read
ASCO Annual Meeting
Apr 23, 2025 Veristat Events
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...